For this reason, the presence of missense SNP in ABCG2, concomitant with other variants in renal drug transporters (SLC29A1 and ABCC4) in heterozygous, could affect the clinical drug efficacy in terms of risk of neutropenia. This evidence concerns the gene SLC29A1 and neutropenia.